National Advisory Committee on Rural Health and Human Services, 38255-38256 [2019-16770]
Download as PDF
<![CDATA[
jbell on DSK3GLQ082PROD with NOTICES
Federal Register / Vol. 84, No. 151 / Tuesday, August 6, 2019 / Notices
shelled; Lentil, succulent shelled.
Contact: RD.
3. EPA File Symbol Numbers: 1021–
EIEO; 1021–EIGN; 1021–EIGR; 1021–
EIEI. Docket ID Number: EPA–HQ–
OPP–2019–0280. Applicant: MGK, 8810
Tenth Avenue North, Minneapolis, MN
55427–4319. Active Ingredient: SI–183
(1R-Phenothrin 98%). Product type:
Insecticide. Proposed Use: Non-food
indoor, outdoor, and residential uses.
Contact: RD
4. EPA File Symbol Number: 1021–
EIGE. Docket ID Number: EPA–HQ–
OPP–2019–0364. Applicant: MGK; 8810
Tenth Avenue North; Minneapolis, MN
55427. Active ingredient: Metofluthrin.
Product type: Insecticide. Proposed Use:
Non-food outdoor residential broadcast
spray. Contact: RD.
5. EPA Registration Number: 10308–
30. Docket ID Number: EPA–HQ–OPP–
2019–0364. Applicant: Sumitomo
Chemical Co., Ltd.; 27–1 Shinkawa, 2chome, Chuo-ku, Tokyo, Japan 104–
8260 (c/o Technology Sciences Group;
1150 18th St. NW, Suite 1000,
Washington, DC 20036). Active
ingredient: Metofluthrin. Product type:
Insecticide. Proposed Use: Non-food
outdoor residential broadcast spray.
Contact: RD.
6. EPA File Symbol Number: 10308–
GT. Docket ID Number: EPA–HQ–OPP–
2019–0280). Applicant: Sumitomo
Chemical Company, Ltd., 27–1
Shinkawa, 2-Chome, Chuo-Ku, Tokyo,
Japan 104–8260 (c/o Technology
Sciences Group Inc., 1150 18th St. NW
Suite 1000, Washington, DC 20036).
Active Ingredient: SI–183 (1RPhenothrin 98%). Product type:
Insecticide. Proposed use: Non-food
indoor, outdoor, and residential uses.
Contact: RD.
7. EPA Registration Numbers: 59639–
185 and 59639–186. Docket ID Number:
EPA–HQ–OPP–2019–0230. Applicant:
Valent U.S.A. LLC, P.O. Box 8025,
Walnut Creek, CA 94596–8025. Active
ingredient: ethaboxam. Product type:
fungicide. Proposed use: seed treatment
on sugar beet. Contact: RD.
8. EPA File Symbol Number: 62719–
TGT. Docket ID Number: EPA–HQ–
OPP–2018–0645. Applicant: Dow
AgroSciences LLC, 9330 Zionsville
Road Indianapolis, IN 46268. Active
ingredient: Florpyrauxifen-benzyl.
Product type: Herbicide. Proposed uses:
Grass forage, fodder, hay, and clover.
Contact: RD.
9. EPA Registration Numbers: 71512–
7; 71512–9; 71512–10 and 71512–14.
Docket ID Number: EPA–HQ–OPP–
2019–0250. Applicant: ISK Biosciences
Corporation, 7470 Auburn Road, Suite
A, Concord, Ohio 44077, requests to
establish a tolerance for residues of the
VerDate Sep<11>2014
19:21 Aug 05, 2019
Jkt 247001
insecticide flonicamid in or on
greenhouse lettuce, and an increase in
the existing tolerance for leafy greens
subgroup 4–16A. Adequate enforcement
methodology (FMC Method No. P–
3561M, a liquid chromatography with
tandem mass spectrometry (LC/MS/MS)
method) is available to enforce the
tolerance expression for flonicamid and
its metabolites in or on plant
commodities. Contact: RD.
10. EPA Registration Number: 87301–
1. Docket ID Number: EPA–HQ–OPP–
2010–0247. Applicant: Biocontrol
Technologies, S.L., Avgda. Madrid, 215–
217, entreso`l A, 08014 Barcelona, Spain
(c/o Wagner Regulatory Associates, Inc.,
P.O. Box 640, Hockessin, DE 19707).
Active ingredient: Trichoderma
asperellum, strain T34. Product type:
Fungicide and Bactericide. Proposed
use: For use outdoors and on food in
agricultural and residential settings to
protect plants against diseases. Contact:
BPPD.
Authority: 7 U.S.C. 136 et seq.
Dated: July 24, 2019.
Delores Barber,
Director, Information Technology and
Resources Management Division, Office of
Pesticide Programs.
[FR Doc. 2019–16732 Filed 8–5–19; 8:45 am]
BILLING CODE 6560–50–P
38255
(NORACoordinator@cdc.gov), National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, Mailstop E–20, 1600 Clifton
Road NE, Atlanta, GA 30329, phone
(404) 498–2581 (not a toll free number).
SUPPLEMENTARY INFORMATION: On
February 5, 2019, NIOSH published a
request for public review in the Federal
Register [84 FR 1736] of the draft
version of the National Occupational
Research Agenda for Hearing Loss
Prevention. NIOSH received three
comments, which were reviewed and
addressed where appropriate. In the
final document, an additional research
need was added, to perform targeted
surveillance of worker hearing,
cardiovascular health, mental health,
and related health outcomes within
worker populations with limited
available research, such as workers in
small construction firms, landscaping
companies, restaurants, bars, sports
arenas and complexes, music venues,
and within public service. A response to
Public Comment document can be
found in the Supporting Documents
section on www.regulations.gov for this
docket.
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2019–16743 Filed 8–5–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[CDC–2019–0001; Docket Number NIOSH–
323]
Health Resources and Services
Administration
Final National Occupational Research
Agenda for Hearing Loss Prevention
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of availability.
AGENCY:
NIOSH announces the
availability of the final National
Occupational Research Agenda for
Hearing Loss Prevention.
DATES: The final document was
published on July 30, 2019 on the CDC
website.
ADDRESSES: The document may be
obtained at the following link: https://
www.cdc.gov/nora/councils/hlp/
agenda.html
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Emily Novicki, M.A., M.P.H,
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
National Advisory Committee on Rural
Health and Human Services
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
National Advisory Committee on Rural
Health and Human Services
(NACRHHS) has scheduled a public
meeting. Information about NACRHHS
and the agenda for this meeting can be
found on the NACRHHS website at
https://www.hrsa.gov/advisorycommittees/rural-health/.
DATES: September 9, 2019, 8:30 a.m.–
5:15 p.m. Eastern Time (ET). September
10, 2019, 8:30 a.m.–5:15 p.m. ET.
September 11, 2019, 8:30 a.m.–11:15
a.m. ET.
SUMMARY:
E:\FR\FM\06AUN1.SGM
06AUN1
38256
Federal Register / Vol. 84, No. 151 / Tuesday, August 6, 2019 / Notices
This meeting will be held
in-person at the Hubert H. Humphrey
Building, located at 200 Independence
Avenue SW, Washington, DC 20201, on
September 9, 2019. The meeting will be
held in-person at the Residence Inn
Washington, Capitol located at 333 E St.
SW, Washington, DC 20024, on
September 10, 2019, and September 11,
2019.
FOR FURTHER INFORMATION CONTACT:
Steven Hirsch, Administrative
Coordinator at the Federal Office of
Rural Health Policy, HRSA, 5600
Fishers Lane, 17W59D, Rockville,
Maryland 20857; 301–443–7322; or
shirsch@hrsa.gov.
SUPPLEMENTARY INFORMATION:
NACRHHS provides advice and
recommendations to the Secretary of
HHS (Secretary) on policy, program
development, and other matters of
significance concerning both rural
health and rural human services.
During the September 9, 2019,
through September 11, 2019, meeting,
NACRHHS will examine the current
delivery of health care and human
services in rural areas. Agenda items are
subject to change as priorities dictate.
Refer to the NACRHHS website for any
updated information concerning the
meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to NACRHHS
should be sent to Steven Hirsch, using
the contact information above, at least
three business days prior to the meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Steven Hirsch at the address and
phone number listed above at least 10
business days prior to the meeting.
Since the meeting on September 10,
2019, occurs in a federal government
building, attendees must go through a
security check to enter the building.
Non-U.S. Citizen attendees must notify
Steven Hirsch of their planned
attendance at least 20 business days
prior to the meeting in order to facilitate
their entry into the building. All
attendees are required to present
government-issued identification prior
to entry.
jbell on DSK3GLQ082PROD with NOTICES
ADDRESSES:
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019–16770 Filed 8–5–19; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
19:21 Aug 05, 2019
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Notice of Interest Rate on Overdue
Debts
Section 30.18 of the Department of
Health and Human Services’ claims
collection regulations (45 CFR part 30)
provides that the Secretary shall charge
an annual rate of interest, which is
determined and fixed by the Secretary
of the Treasury after considering private
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 105⁄8%, as fixed by
the Secretary of the Treasury, is certified
for the quarter ended June 30, 2019.
This rate is based on the Interest Rates
for Specific Legislation, ‘‘National
Health Services Corps Scholarship
Program (42 U.S.C. 254o(b)(1)(A))’’ and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
debt until the Department of Health and
Human Services publishes a revision.
Dated: July 30, 2019.
David C. Horn,
Director, Office of Financial Policy and
Reporting.
[FR Doc. 2019–16747 Filed 8–5–19; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Division of Epidemiology and Disease
Prevention; Epidemiology Program for
American Indian/Alaska Native Tribes
and Urban Indian Communities Ending
the HIV Epidemic in Indian Country
Announcement Type: Competing
Supplement
Funding Announcement Number: HHS–
2019–IHS–EPI–0001
Assistance Listing (Catalog of Federal
Domestic Assistance or CFDA)
Number: 93.231
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Key Dates
Application Deadline Date: September
5, 2019
Earliest Anticipated Start Date:
September 30, 2019
I. Funding Opportunity Description
Statutory Authority
The Indian Health Service (IHS)
Office of Public Health Support,
Division of Epidemiology and Disease
Prevention (DEDP), in partnership with
the IHS Office of Clinical and
Preventive Services (OCPS) National
Human Immunodeficiency Virus (HIV)
& Viral Hepatitis C (HCV) Program and
the U.S. Department of Health and
Human Services (HHS) Minority HIV/
AIDS Fund (MHAF) is accepting
applications for competitive
supplemental funds to enhance
activities in the Epidemiology Program
for American Indian/Alaska Native (AI/
AN) Tribes and Urban Indian
communities. This program is funded
by the Office of the Assistant Secretary
for Health, HHS, is authorized under the
statutory earmark for minority AIDS
prevention and treatment activities, and
is to be carried out pursuant to Title III
of the Public Service Act. The funding
is being made available through an
intra-Departmental Delegation of
Authority (IDDA) to award specific
funding for fiscal year (FY) 2019. This
program is described in the Assistance
Listings located at https://beta.sam.gov
(formerly known as Catalog of Federal
Domestic Assistance) under 93.231.
Background
The Tribal Epidemiology Center (TEC)
program was authorized by Congress in
1996 as a way to provide public health
support to multiple Tribes and Urban
Indian communities in each of the IHS
Areas. Only current TEC grantees are
eligible to apply for the competing
supplemental funding under this
announcement and must demonstrate
that they have complied with previous
terms and conditions of the TEC
program.
The Office of Infectious Disease and
HIV/AIDS Policy (OIDP) is located
within the Office of the Assistant
Secretary for Health HHS. The OIDP has
directed the IHS to make awards to
conduct projects and activities in
support of the Ending the HIV
Epidemic: A Plan for America initiative
(EHE). The purpose of MHAF is to
reduce new HIV infections, improve
HIV-related health outcomes, and to
reduce HIV-related health disparities for
racial and ethnic minority communities
by supporting innovation, collaboration,
and the integration of best practices,
E:\FR\FM\06AUN1.SGM
06AUN1
]]>Agencies
[Federal Register Volume 84, Number 151 (Tuesday, August 6, 2019)]
[Notices]
[Pages 38255-38256]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16770]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Advisory Committee on Rural Health and Human Services
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's National Advisory Committee on
Rural Health and Human Services (NACRHHS) has scheduled a public
meeting. Information about NACRHHS and the agenda for this meeting can
be found on the NACRHHS website at https://www.hrsa.gov/advisory-committees/rural-health/.
DATES: September 9, 2019, 8:30 a.m.-5:15 p.m. Eastern Time (ET).
September 10, 2019, 8:30 a.m.-5:15 p.m. ET. September 11, 2019, 8:30
a.m.-11:15 a.m. ET.
[[Page 38256]]
ADDRESSES: This meeting will be held in-person at the Hubert H.
Humphrey Building, located at 200 Independence Avenue SW, Washington,
DC 20201, on September 9, 2019. The meeting will be held in-person at
the Residence Inn Washington, Capitol located at 333 E St. SW,
Washington, DC 20024, on September 10, 2019, and September 11, 2019.
FOR FURTHER INFORMATION CONTACT: Steven Hirsch, Administrative
Coordinator at the Federal Office of Rural Health Policy, HRSA, 5600
Fishers Lane, 17W59D, Rockville, Maryland 20857; 301-443-7322; or
[email protected].
SUPPLEMENTARY INFORMATION: NACRHHS provides advice and recommendations
to the Secretary of HHS (Secretary) on policy, program development, and
other matters of significance concerning both rural health and rural
human services.
During the September 9, 2019, through September 11, 2019, meeting,
NACRHHS will examine the current delivery of health care and human
services in rural areas. Agenda items are subject to change as
priorities dictate. Refer to the NACRHHS website for any updated
information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to NACRHHS should be
sent to Steven Hirsch, using the contact information above, at least
three business days prior to the meeting. Individuals who plan to
attend and need special assistance or another reasonable accommodation
should notify Steven Hirsch at the address and phone number listed
above at least 10 business days prior to the meeting. Since the meeting
on September 10, 2019, occurs in a federal government building,
attendees must go through a security check to enter the building. Non-
U.S. Citizen attendees must notify Steven Hirsch of their planned
attendance at least 20 business days prior to the meeting in order to
facilitate their entry into the building. All attendees are required to
present government-issued identification prior to entry.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-16770 Filed 8-5-19; 8:45 am]
BILLING CODE 4165-15-P
